145901-11-7

Basic information

• Product Name: 6-NITRO-1H-PYRROLO[2,3-B]PYRIDINE
• Synonyms: 6-AMINO-7-AZAINDOLE;6-NITRO-1H-PYRROLO[2,3-B]PYRIDINE;1H-pyrrolo[2,3-b]pyridin-6-amine;1H-Pyrrolo[2,3-b]pyridin-6-amine(9CI);1H-Pyrrolo[2,3-b]pyridin-6-ylaMine
• CAS NO: 145901-11-7
• Molecular Formula: C₇H₇N₃
• Molecular Weight: 163.13
• EINECS: 145-896-5
• Product Categories: PYRIDINE
• Mol File: 145901-11-7.mol
• Article Data: 12

Chemical Properties

• Melting Point: 126.7℃
• Boiling Point: 354.651 °C at 760 mmHg
• Flash Point: 195.469 °C
• Appearance: /
• Density: 1.367 g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.78
• Storage Temp.: 2-8°C(protect from light)
• CAS DataBase Reference: 6-NITRO-1H-PYRROLO[2,3-B]PYRIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: 6-NITRO-1H-PYRROLO[2,3-B]PYRIDINE(145901-11-7)
• EPA Substance Registry System: 6-NITRO-1H-PYRROLO[2,3-B]PYRIDINE(145901-11-7)

Safety Data

• Statements: 36
• Safety Statements: 26
• Hazardous Substances Data: 145901-11-7(Hazardous Substances Data)

Usage

General Description

6-NITRO-1H-PYRROLO[2,3-B]PYRIDINE is a chemical compound with the molecular formula C8H6N4O2. It is a nitro-substituted heterocyclic compound that is used in the field of organic synthesis and medicinal chemistry. 6-NITRO-1H-PYRROLO[2,3-B]PYRIDINE has potential applications as a building block in the synthesis of pharmaceuticals and agrochemicals. Its unique structure and reactivity make it a valuable intermediate in the development of novel molecules with biological activity. Furthermore, its nitro-group functionality provides opportunities for further derivatization and modification, making it a versatile and important compound in the field of chemical research and development.

InChI:InChI=1/C7H7N3/c8-6-2-1-5-3-4-9-7(5)10-6/h1-4H,(H3,8,9,10)

Upstream product

• 141-86-6 2.6-diaminopyridine 
• 107-21-1 ethylene glycol 
• 55052-27-2 6-chloro-7-azaindole 
• 55052-24-9 1H-Pyrrolo[2,3-b]pyridine-7-oxide 
• 143468-13-7 6-Bromo-1H-pyrrolo<2,3-b>pyridine 
• 138343-75-6 tert-butyl (3-methylpyridin-2-yl)carbamate 
• 1603-40-3 3-methylpyridin-2-ylamine 
• 271-63-6 7-Azaindole 

Downstream Products

• 1346447-43-5 tert-butyl 1H-pyrrolo[2,3-b]pyridin-6-ylcarbamate 
• 1342811-68-0 N-(4-fluorophenyl)-1H-pyrrolo[2,3-b]pyridin-6-amine 
• 1446791-65-6 2-(1H-pyrrolo[2,3-b]pyridin-6-yl)isoindoline-1,3-dione 
• 1446790-54-0 6-((1R,2S)-2-amino-cyclohexylamino)-4-(1-methyl-1H-pyrrolo[2,3-b]pyridin-6-ylamino)-pyridazine-3-carboxylic acid amide 
• 1446791-74-7 {(1S,2R)-2-[6-carbamoyl-5-(1-methyl-1H-pyrrolo[2,3-b]pyridin-6-ylamino)-pyridazin-3-ylamino]-cyclohexyl}-carbamic acid tert-butyl ester 
• 1446791-69-0 1-methyl-1H-pyrrolo[2,3-b]pyridin-6-ylamine 

Relevant articles and documents

Functionalization of 1H-Pyrrolopyridine

Functionalization of 1H-pyrrolopyridine (7-azaindole) was studied to provide new compounds directing toward agrochemicals and/or functional materials.Amino groups such as NH2, NH(CH2)2NH2, and NH(CH2)2NH(CH2)2NH2 were introduced onto 6-position of

Preparation method of drug composition for treating febrile convulsion in children

The invention relates to a preparation method of a drug composition for treating febrile convulsion in children. The method comprises a route as shown in the specification. A treatment mechanism of the drug of the invention is to prolong the convulsion latency of a febrile convulsion patient, shorten the convulsion duration, relieve the convulsion seriousness, inhibit apoptosis of hippocampal neurons, regulate the levels of GABA and Glu, relieve the cerebral injury of febrile convulsion patient and finally achieve the purpose of treating the febrile convulsion.

Heterocyclic compounds

The present invention relates to a novel heterocyclic compound or to pharmaceutically acceptable salts and solvates thereof. The pharmaceutical composition or cosmetic composition comprising, as active ingredients, the compound or pharmaceutically acceptable salts and solvates thereof may be effectively used in the treatment or prevention of skin diseases.